Pegassist
Where Patients Matter
Type a Question Go
Brought to you by the makers of PEGASYSŪ (Peginterferon alfa-2a)
Healthcare Professionals
Patient Education Materials
24-7 Nurse Support
Support Specifically Designed for Your Use During Treatment with PEGASYS
Already a Member? Login Now
Forgot
Password?
Not a member? Sign up is simple
About Pegassist
What is Pegassist?

Pegassist is a comprehensive patient education and support program. It provides important information about hepatitis C, treatment options, and tips for daily living when you have hepatitis C. The services offered here on Pegassist.com are just part of the total Pegassist program.

To sign up for additional Pegassist features, all you have to do is call our toll-free number: 1-877-PEGASYS (1-877-734-2797).

Understanding hepatitis C

Pegassist is dedicated to helping you—and those closest to you—learn more about hepatitis C. In addition to the information provided on this site, the following brochures are available to you:

Hepatitis C: What You Should Know brochure: This comprehensive brochure helps you educate patients about hepatitis C. It answers many questions patients have and supplements your teaching. It also provides more detailed answers to the questions presented on the patient assessment tool. Patients can share this brochure with family and friends.

Available in English, Spanish, Chinese, Korean, Russian, and Vietnamese

Q&A: Answers to Your Common Questions : Answers basic questions about hepatitis C and treatment with PEGASYS and COPEGUS® (Ribavirin,USP), and the importance of staying with your treatment.

Available in English, Spanish, Chinese, Korean, Russian, and Vietnamese

Hep C Tests handout: This informative patient handout explains the usual blood tests and diagnostic procedures a patient undergoes once diagnosed with hepatitis C. Graphics show the location of the liver in the body and illustrate liver damage to help you describe what you are evaluating when performing these tests and procedures.

Vietnamese

Available in English, Spanish, Chinese, Korean, Russian, and Vietnamese

Self-injection guide for PEGASYS: Detailed instructions for the best way to use PEGASYS syringes.

Available in English

Hepatitis C—Life During Treatment brochure: This brochure supplements your discussions on treatment, side effects, and success rates. It also helps to motivate patients, manage their expectations, prepare for issues that may arise and encourages them to seek support from healthcare providers, friends and family and the Pegassist program.

Available in English, Spanish, Chinese, Korean, Russian, and Vietnamese

What you need to know about hepatitis C when you have HIV: Basic information about hep C, how hep C treatment may affect HIV, treatment options, and support with Pegassist.

Available in English and Spanish

Fighting hepatitis C when you have HIV: Common questions about hep C treatment with PEGASYS and COPEGUS for people with HIV.

Available in English and Spanish

When You Know Someone Who Has Hepatitis C handout: This handout is meant for patients to share with their family or friends. It covers facts about hepatitis C, how spreading hepatitis C can be prevented and how family and friends can support the person who is undergoing treatment.

Available in English, Spanish, Chinese, Korean, Russian, and Vietnamese

Side effect sheets : Discuss steps you can take if you experience these side effects:

Note: These brochures are provided in Adobe Acrobat Reader format (PDF). To view or print them, you must have Adobe Acrobat Reader (version 3.0 or higher) installed on your computer. If you do not have the Reader, you can obtain it free from Adobe Corporation.

Click on the icon below to download the program from their Web site.

Get Acrobat Reader

Pegassist also offers some materials and services just for patients on PEGASYS:

  • Guides and self-injection videos provide step-by-step instructions on how to properly inject PEGASYS.
    • For patients starting with PEGASYS Prefilled Syringes:
    • For patients starting with PEGASYS vials:
    • NOTE: These guides are provided in Adobe® Acrobat® Reader® format (PDF). To view or print them, you must have Adobe Acrobat Reader (version 3.0 or higher) installed on your computer. If you do not have the Reader, you can obtain it free from Adobe Corporation. Click on the icon below to download the program from their Web site.

      Get Acrobat Reader

  • The PEGASYS patient starter kit: This kit contains almost everything patients need to take their first dose of PEGASYS, including a self-injection video and guide; hepatitis C/PEGASYS video; handbook on hepatitis C and PEGASYS; and other items, including a water bottle, travel case, and first aid kit. The kit also contains a pregnancy test kit and important information regarding pregnancy prevention for patients and their partners.
  • A toll-free telephone number to talk to nurses—24 hours a day, 7 days a week—who will provide guidance throughout your treatment with PEGASYS alone or in combination with COPEGUS® (Ribavirin, USP). Call 1-877-PEGASYS (1-877-734-2797).
  • Newsletters: Patients who enroll in the Pegassist program receive monthly newsletters (12 total). These newsletters contain information about PEGASYS, motivational quotes, and helpful tips—including low-fat recipes. You can also sign up now to get them via e-mail if you haven't already!

Call toll-free at 1-877-PEGASYS (1-877-734-2797) to get full information about all of these features.

Safety Information

What is PEGASYS?

PEGASYS is a medicine used to treat some adults who have hepatitis C and signs of liver damage. PEGASYS works to reduce the amount of virus in your blood, helping your body fight the virus.

PEGASYS® (Peginterferon alfa-2a), like other alpha interferons, can cause fatal or make life-threatening problems worse (like mental, immune system, heart, liver, lung, intestinal and infections). Your doctor should monitor you during regular visits. If you show signs or symptoms of these conditions, your doctor may stop your medication. In most patients, these conditions get better after you stop taking PEGASYS (see medication guide for more information and warnings).

What is COPEGUS?

COPEGUS is a medicine that works by slowing down the growth of the virus. COPEGUS should be taken with PEGASYS to fight the virus. Do not take COPEGUS by itself.

COPEGUS® (Ribavirin, USP) can be extremely harmful and cause birth defects in an unborn baby. Female patients and the female partners of male patients should avoid getting pregnant. Ribavirin is known to cause anemia (low red blood cells), which can make heart disease worse. Also, ribavirin can harm your DNA and possibly cause cancer (see medication guide for more information and warnings).

Who should not take PEGASYS and COPEGUS?

Do not take PEGASYS alone or with COPEGUS if:

  • You are pregnant or your partner is pregnant
  • You or your partner plans to get pregnant during therapy or within 6 months after treatment ends
  • You are breastfeeding
  • You have hepatitis caused by your immune system (autoimmune hepatitis)
  • You have unstable or severe liver disease before or during treatment
  • You are allergic to alpha interferons or any of the ingredients in PEGASYS and COPEGUS
  • You have abnormal red blood cells (caused by conditions like sickle-cell anemia or thalassemia major)

What if I am pregnant or thinking about having a baby?

If you are a woman who could get pregnant, you must take pregnancy tests before, during and for 6 months after treatment ends to make sure you are not pregnant.

During treatment and for 6 months after treatment, female and male patients must:

  • Use two forms of birth control (one being a condom with spermicide)
  • Tell your doctor right away if you or your partner becomes pregnant. You or
    your doctor should also call the Ribavirin Pregnancy Registry at 1-800-593-2214

What medication should I avoid when I am taking PEGASYS and COPEGUS?

You should not take didanosine with COPEGUS. Talk to your doctor about all medications that you are taking.

What are the possible side effects?

The most common side effects of PEGASYS and COPEGUS are:

  • Flu-like symptoms (including fever, chills, muscle aches, joint pain, headaches)
  • Tiredness
  • Upset stomach (like nausea, taste changes, diarrhea)
  • Blood sugar problems (may lead to diabetes)
  • Skin problems (like rash, dry or itchy skin, redness and swelling at injection site)
  • Hair loss (temporary)
  • Trouble sleeping

The most serious side effects of PEGASYS and COPEGUS are:

  • Risks to pregnancies
  • Mental health problems (such as irritability, depression, anxiety, aggressiveness, trouble with drug addiction or overdose, thoughts about suicide, suicide attempts, suicide and thoughts about homicide)
  • Blood problems (like a drop in blood cells leading to increased risk for infections, bleeding and/or heart or circulatory problems)
  • Infections (which sometimes cause death)
  • Lung problems (like trouble breathing, pneumonia)
  • Eye problems (like blurred vision, loss of vision)
  • Autoimmune problems (such as psoriasis, thyroid problems)
  • Heart problems (including chest pain and, rarely, a heart attack)
  • Liver problems (rarely, liver function worsens). Patients with both the hepatitis C virus and HIV can have an increased chance of having liver failure during PEGASYS treatment. Change in a blood test that measures liver inflammation occurs more often in patients with hepatitis B. If you have a rise in this blood test you may need to be watched more closely with additional blood tests.

Tell your doctor immediately if you think you or your partner may be pregnant or if any of these symptoms occur.

This information does not take the place of talking to your healthcare professional about your medical condition or your treatment.

Please see the medication guides and complete product information for PEGASYS and COPEGUS.

 

THIS SITE INTENDED FOR U.S. AUDIENCES ONLY

For more information about PEGASYS, contact your physician or other healthcare professional.

Roche
Copyright © 2003-2008 Hoffmann-La Roche Inc. All rights reserved. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and PRIVACY Statement. Because Pegassist.com offers some unique features and options, Roche provides additional protection tailored to those items. Click here to read Additional Details about your Privacy.
   
eHealthcare Leadership Awards 2004 Winner, Gold Award: Best Care/Disease Management Site Brought to you by the makers of PEGASYS® (Peginterferon alfa-2a)
Gold Award:
Best Care/Disease
Management Site